🚀 Data science is redefining healthcare! In our Data Bytes session with Nehal Doshi from Verici Dx, she talked about converting vast amounts of data into actionable insights to tackle the complexities of personalized medicine. This discussion also highlights Tutivia, a test that could revolutionize kidney transplant care. With its unique RNA signature technology, Tutivia offers early detection of acute rejection, promising a future where treatments are uniquely tailored to each patient. Curious to learn more? Download our detailed case study here 👉 https://lnkd.in/dDBhVyB9
BioLizard
Biotechnology Research
Ghent, Flemish Region 6,022 followers
🦎 Our Lizards adapt to your (data) environment! Data science | Bioinformatics | AI | Software development | Data mgmt
About us
BioLizard is a leading multi-national data analytics and data management consulting company supporting digital transformation in the life sciences industry by offering bespoke, tailored solutions. From data analytics and bioinformatics, to software development and AI, we support biopharma and biotech companies in accessing vital, data-driven insights that can be turned into actions and drive your life sciences research forward. Our team of experienced bioengineers, software engineers and computer science experts combines extensive data science expertise with deep biological knowledge to provide solutions that are tailored to your needs and in line with your unique strategic goals. We have a proven ability to support companies from discovery to pre- & early clinical phases, enabling data-driven R&D. Our expertise spans drug and biomarker discovery and development, in silico screening, target identification, development of companion diagnostics, mechanism-of-action studies, process automation, data strategy, and more. As your true data partner, we’re ready to help you leverage data to keep your competitive edge. Our expert ‘Lizards’ can support you no matter where you are in the world, and in a flexible, proactive, and agile way to drive your data-driven research forward. 𝗥𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝘁𝗼 𝗕𝗶𝗼𝗟𝗶𝘇𝗮𝗿𝗱 𝘁𝗼𝗱𝗮𝘆 𝘁𝗼 𝘀𝘁𝗮𝗿𝘁 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝘆𝗼𝘂𝗿 𝗯𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗮𝘁𝗮 𝗶𝗻𝘁𝗼 𝗮𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀. More information: https://lizard.bio/home Company video: https://www.youtube.com/watch?v=q9MR126aiNo&t=1s BioLizard careers: https://lizard.bio/careers
- Website
-
https://lizard.bio/home
External link for BioLizard
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Ghent, Flemish Region
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Machine learning, Single-cell sequencing, Data management, Personalised medicine, Bioinformatics, Microbiome analysis, Pipeline development, Biomarker detection & validation, Protein structure prediction, Genomics, omics data analysis, data integration, Biostatistics, and Analysis automation
Locations
-
Primary
Foreestelaan 88
Ghent, Flemish Region 9000, BE
-
Ottergemsesteenweg
Ghent, Flemish Region 9000, BE
-
Herengracht 420
Amsterdam, North Holland 1017, NL
-
1700 W Irving Park Rd
Chicago, Illinois 60613, US
Employees at BioLizard
Updates
-
💡 Transform your R&D performance with AI-driven data management! Enhance your scalable data strategy and high-quality data governance to unlock advanced analytics (ML & AI) applications. 🔍 Build a comprehensive, strategic plan with a step-wise implementation strategy for infrastructure that spans the entire drug, biomarker, and diagnostic development pipeline. Seamlessly integrate AI into your environment as a standard procedure to improve lead candidate selection. 🚀 Not sure how to identify future AI opportunities? We're here to help! We will: - Conduct a comprehensive FAIR assessment to highlight strengths and areas for improvement. - Evaluate infrastructure requirements. - Identify low-hanging fruit for AI-driven proof of concept (PoC) implementations. Get in touch with us today and get 15% off your journey towards a more efficient and innovative R&D process! 👉 https://lnkd.in/dmh4DSkk #AI #DataManagement #R&D #AdvancedAnalytics #MachineLearning #DrugDevelopment
-
💡 Transform your R&D performance with AI-driven data management! Enhance your scalable data strategy and high-quality data governance to unlock advanced analytics (ML & AI) applications. Get in touch with us today👉 https://lnkd.in/dSMTVa3k
AI data management: improve overall R&D performance, implement scalable data strategy and high quality data governance to enable advanced analytics (ML & AI) applications - 15% off stage 1 | Research Services
info.scientist.com
-
🔍 Today’s #interestingread highlights a critical perspective on the use of computational predictive models in drug discovery. This article emphasizes the importance of rigour and transparency in developing and interpreting predictive models. It sheds light on common pitfalls and biases that can mislead research efforts and discusses best practices to ensure the reliability and accuracy of computational predictions, such as: ✅ Model Validation: We need rigorous validation techniques to avoid overfitting and ensure that models generalize well to new data. 🔄 Transparency and Reproducibility: Clear documentation and sharing of data and methodologies are necessary to enhance reproducibility and trust in model predictions. 🛑 Bias Mitigation: Implement strategies to identify and mitigate biases in data and model development, which are crucial for accurate and equitable drug discovery, and real-world applicability. 💡 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲: https://lnkd.in/dE2KVizv Want to ensure your data has meaningful outcomes and need assistance in data-driven decision-making? We’ve got you covered, contact us now 👉 https://lnkd.in/dAarw6x8 #DrugDiscovery #PredictiveModels #DataIntegrity #ComputationalBiology #Innovation #DataDrivenScience #Transparency
How to Lie With Computational Predictive Models in Drug Discovery – DrugDiscovery.NET – AI in Drug Discovery
drugdiscovery.net
-
Kidney transplant recipients still face high rejection rates, but personalised predictive diagnostics are revolutionizing care! In our new Data Bytes session, Patti Connolly discusses developing Verici Dx's first product, Tutivia, and working with BioLizard to achieve their goals. Rooted in over a decade of research, Tutivia leverages RNA signatures to predict acute rejection after kidney transplant, providing a more precise, early diagnosis than traditional biomarkers. This innovative, non-invasive tool improves patient outcomes and tackles the urgent need for better long-term graft survival. Curious to learn more? Download our detailed case study here 👉 https://lnkd.in/dDBhVyB9
-
📚✨ Unlock the power of seamless literature preparation with Bio | Reflect! For a limited time, enjoy 15% off your first fast-track literature preparation for regulatory approval or exploratory reading. 🚀 Fast-track your project life cycle from initial exploration to patents, clinical trials, and regulatory approval. Bio | Reflect helps you select the most relevant scientific literature, linking it directly to your data for comprehensive scientific exploration. 🔬 With Bio | Reflect, you benefit from: - Seamlessly integrated disease, gene, and chemical annotations - Uncovering gene-disease associations and more from publications - An unbiased, at-a-glance, and up-to-date global overview of publications with topic-based clustering 🌐 Dreaming of breezing through your literature searches with ease? Get in touch 👉 https://lnkd.in/eac5VRS4 #ScientificResearch #LiteratureReview #RegulatoryApproval #BioReflect
-
-
🦎 We have an exciting #jobopportunity at BioLizard! 💼 🚀 We are looking for a 🧬 single cell bioinformatics scientist to support our team in working on challenging life science projects. In this position, you will be responsible for developing solutions for data integration, pipeline implementation, machine learning, and data visualisation, with a focus on single-cell and spatial data analysis. You should be adept at experimental design, and computational omics, with a strong passion for analysing single-cell data to derive valuable scientific insights for our clients. Ready to join our team? 𝗔𝗽𝗽𝗹𝘆 𝗵𝗲𝗿𝗲 👉 https://lnkd.in/d9bbm-sU
-
-
Are you looking to improve R&D productivity within your organisation? This #interestingread looks at how the major revision of AstraZeneca’s R&D strategy improved their productivity. Changes they implemented across target validation, screening, optimization, safety testing and decision-making yielded higher-quality projects and increased success rates. 💡 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲: https://lnkd.in/dM6-QrCu
Impact of a five-dimensional framework on R&D productivity at AstraZeneca - Nature Reviews Drug Discovery
nature.com
-
𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗣𝗹𝗮𝗻𝘁 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗺𝗲𝘀 🌿 Harnessing the potential of plant microbiomes is key to driving sustainable agriculture and improving crop resilience. But how can you tap into this hidden resource? 🤔 Not sure where to start? Our blog series takes you on a journey through the green frontier, offering practical insights and strategies: 💡 Rooted in Science: The importance of plant microbiomes 👉 https://lnkd.in/dzMYC8qZ 💡 Three ways you can extract information from plant microbiomes 👉 https://lnkd.in/ddycu4Su 💡 Microbial network analysis: How to unravel interactions between taxa 👉 https://lnkd.in/dWzkY95T Ready to explore your plant microbiomes? Connect with BioLizard today and let’s innovate together! 🌿
-
-
🔬🌟 Bridge the in-vivo to human studies gap in your target discovery pipeline with Bio|Mx and enjoy 15% off your first project! Are you aiming to discover new therapeutic targets and elucidate therapeutic mechanisms of action but find your dataset limited? Now's your chance to integrate and extract biological signals from highly heterogeneous public datasets where other multi-omics integration methods would fail. 🚀 Be a pioneer in multi-omics integration! Combine public and proprietary omics datasets to gain a comprehensive overview of your biological systems in your disease context. With Bio|Mx, leverage advanced machine learning methods and a powerful, user-friendly interface to create actionable insights. Contact us now 👉 https://lnkd.in/dTq_Jytr #BioMx #MultiOmics #TherapeuticDiscovery #MachineLearning #ScientificResearch #BiotechInnovation
-